In connection with Section 16a of “Best Practices of Companies Listed on NewConnect”, the Board of Directors of Milestone Medical Inc. (the "Company", “The Issuer”) informs about incidental violation of information duty specified in §3 section 1 point 11) of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market". The violation relates to delay in submission of the reports of the EBI number 2/2018 in terms of the change in the position of Chief Executive Officer.
The reason of delay in publishing the reports was unintended omission made by the Company. The company released the report immediately after the disclosure of mistakes. In view of the situation, the Company declares further reliable and accurate fulfillment of disclosure obligations. The Board of Directors of the Company will provide necessary actions to ensure that such case will not happen again in the future.
Legal basis : Section 16a of Exhibit 1 to Resolution No. 293/2010 of the Management Board of the Warsaw of 31 March 2010 on the amendment of the „Best Practices of Companies Listed on NewConnect”
Osoby reprezentujące spółkę:
Joseph D'Agostino - Chief Financial Officer